general bases and ammonium group general acids near
neutrality, and thus can act as efficient transaminase mimics.
Recently, we have described transaminase mimics consisting
of pyridoxamines covalently linked to branched PEIs,
carrying long-chain alkyl chains. They converted R-keto
acids to amino acids with up to a 240000-fold rate enhance-
ment relative to the reaction with simple pyridoxamine at
the same total pyridoxamine concentration.10-12 We have also
used noncovalent polymer-pyridoxamine systems as enzyme
mimics, in which pyridoxamines carrying hydrophobic side
chains boundsalong with the substratessinto hydrophobic
regions of the PEIs.13 The latter showed even better rate
enhancement, as much as 725000-fold with the hydrophobic
indolepyruvic acid that forms tryptophan.14 In all of these
cases, the polymer, being achiral, formed racemic mixtures
of the product amino acids.
Scheme 2. Synthesis of 1
ylenimine) 2 with a base (Scheme 2), following Saegusa’s
method.16,17 The methyl group of the butoxy group served
as the NMR probe for the determination of degree of
polymerization. Complete absence of the formyl groups in
the hydrolyzed product 1 was confirmed by IR spectroscopy,
where the strong formyl CdO stretching at 1668 cm-1 of 2
1
Incorporating the features of hydrophobicity in a chiral
environment, and general acid-general base catalyst, we
have briefly described a transaminase mimic with non-
covalently bound pyridoxamine-chiral polyethylenimine
systems (Scheme 1).15
disappeared, and also by H NMR spectroscopy, where the
broad formyl proton peak around δ 7.7 of the precursor was
absent.
The average degree of polymerization (DP) with 2 mol
% of initiator (compared to the oxazoline) was ca. 50, with
3 mol % was ca. 30, and with 6 mol % was ca. 13. The
polydispersity of the chiral PEI’s determined by GPC were
1.01, 1.07, and 1.20 for the 50-mer, 30-mer, and the 13-
mer, respectively. The low polydispersity values are in
accordance with the highly living nature of the polymeriza-
tion, where the DP values are very close to the oxazoline/
initiator ratio.18 Prior to our work, Goodman et al. had
synthesized optically active polyoxazolines (including the
50 mer 2) following Saegusa’s method, and from circular
dichroism studies had shown that polyoxazolines obtained
via this kind of cationic ring opening polymerization are
isotactic in nature.19
Scheme 1. Transamination with 1a
The (S)-benzyl side chains of the polymers 1 can form a
chiral hydrophobic pocket in which the nonpolar alkyl chains
of the pyridoxamine coenzyme 413 can bind, and thus, the
transamination reaction can take place in a chiral environ-
ment, as in the natural system, to give chiral induction in
the amino acid products. Indeed, high enantioselectivity was
achieved when the 50-mer in ca. 40% aqueous methanol (v/
v%) at pH 7.3-7.8 produced L/D valine with a ratio of 83/
17 (ca. 5-7% conversion), but unfortunately the amino acid
racemized at higher conversion. The ratio of L/D valine with
the 30- and 13-mers were slightly less (78/22 and 71/29,
respectively). Enantioselectivity at the initial stage of tran-
samination, followed by racemization of the amino acid
products, was also reported by Bernauer with Cu(II) com-
plexes of C2-symmetric ligands and Schiff bases of keto acids
and pyridoxamine.20
a Reaction conditions: 5.0 × 10-4 mol/L of pyridoxamine 4, 10
g/L of PEI, 5 × 10-4 EDTA, 5 × 10-3 mol/L of 3-methyl-2-
oxopyruvic acid, t ) 20-25 °C. pH values reported here are as
read with a glass-electrode calibrated against aqueous buffers.
The chiral PEI 1 with (S)-benzyl side chains was synthe-
sized from 4-(S)-4-benzyl-2-oxazoline 3 via a cationic ring-
opening polymerization using methyl tosylate as the initiator
and 1-butanol as the terminator and subsequent deformylation
of the N-formamide groups of poly(N-formyl-1-benzyleth-
Interestingly, racemization was never observed with py-
ridoxamines that were covalently attached to other catalytic
units, including amines.7,8 We believe that the Schiff base
(10) Liu, L.; Rozenman, M.; Breslow, R. J. Am. Chem. Soc. 2002, 124,
12660-12661.
(11) Zhou, W. J.; Liu, L.; Breslow, R. HelV. Chim. Acta 2003, 86, 3560-
3567.
(12) Liu, L.; Breslow, R. J. Am. Chem. Soc. 2002, 124, 4978-4979.
(13) Liu, L.; Zhou, W. J.; Chruma, J.; Breslow, R. J. Am. Chem. Soc.
2004, 126, 8136-8137.
(16) Saegusa, T.; Fujii, H.; Ikeda, H. Polym. J. 1972, 3, 35-39.
(17) Saegusa, T.; Fujii, H.; Ikeda, H. Macromolecules 1972, 5, 108.
(18) Kobayashi, S.; Iijima, S.; Igarashi, T.; Saegusa, T. Macromolecules
1987, 20, 1729-1734.
(14) Chruma, J. J.; Liu, L.; Zhou, W.; Breslow, R. Bioorg. Med. Chem.
2005, 13, 5873-5883.
(19) Oh, Y. S.; Yamazaki, T.; Goodman, M. Macromolecules 1992, 25,
6322-6331.
(15) Breslow, R.; Bandyopadhyay, S.; Levine, M.; Zhou, W. Chembio-
Chem 2006, 7, 1491-1496.
(20) Chuard, T.; Gretillat, F.; Bernauer, K. Chimia 1993, 47, 215-217.
1010
Org. Lett., Vol. 9, No. 6, 2007